Bioassay-guided fractionation of the chloroform soluble fraction of stem, leaf, and flower extracts of the American plant Ivesia gordonii led to the isolation of a new dimeric acylphloroglucinol, 3,3′-diisobutyryl-2,6′-dimethoxy-4,6,2′,4′-tetrahydroxy-5,5′dimethyldiphenyl methane (1), to which we have assigned the trivial name of ivesinol (1), together with a known monomeric acylphloroglucinol, 1,5-dihydroxy-2-(2′-methylpropionyl)-3-methoxy-6-methylbenzene (2). The structures of the isolated compounds were characterized using 1D-and 2D-NMR spectroscopy, including COSY, HMQC, HMBC, and ROESY experiments, as well as mass spectrometry. Ivesinol (1) showed potent activity against Staphylococcus aureus (SA) and methicillin-resistant S. aureus (MRSA) with IC 50 /MIC/MBC values of 0.10/1.25/>20 g/mL and 0.05/0.31/>20 g/mL, respectively (vs. IC 50 /MIC/MBC 0.13/0.5/1.0 g/mL and 0.13/0.5/1.0 g/mL of ciprofloxacin), while the corresponding monomer 2 was found to be less active. Compound 1 also demonstrated strong activity against vancomycin-resistant Enterococcus faecium (VRE) with IC 50 /MIC/MBC values of 0.22/1.25/>20 g/mL, whereas the reference standard ciprofloxacin was found to be inactive against this strain. In addition, compound 2 showed moderate activity against two species of Candida and Cryptococcus neoformans, while 1 was inactive against these fungi. In order to evaluate the influence of the acyl group(s) in phloroglucinol (3) as a ligand, the mono-(4) and diacetylphloroglucinol (5) were prepared from 3, and evaluated for their in vitro SA, MRSA, and VRE activities; 2,4-diacetylphloroglucinol (5) showed potent activity, like 1, against SA, MRSA, and VRE (ATCC 700221) with IC 50 / MIC values of 0.3/2.5, 0.23/2.5, and 0.86/2.5 g/mL, respectively, while 4 was inactive.
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE) represent two potential threats to human health. MRSA can be categorized as either hospital-acquired (HA-MRSA) or community-associated (CA-MRSA) (1) . HA-MRSA is a hospital-acquired infection while CA-MRSA is caused by newly emerging strains different from those causing HA-MRSA. CA-MRSA infections typically occur on the skin; however, they can develop into systemic life-threatening conditions. According to the Centers for Disease Control and Prevention (CDC), MRSA can cause serious health problems such as bloodstream infections and pneumonia. CA-MRSA is occurring with a higher incidence rate in the United States and in particular amongst people who are in close physical contact, such as football athletes and childcare workers (2) . According to the National Institutes of Allergy and Infectious diseases, NIH, during the past four decades, MRSA has devolved from a controllable nuisance into a severe public health concern. A recent national estimate for invasive MRSA incidence rates showed one in three people carry Staph in their nose and two in 100 people carry MRSA.
Enterococci bacteria have the ability to survive for months in humans and animals. Similar to MRSA, VRE infections are commonly acquired by hospitalized patients. VRE is classified into two main categories, the intrinsic resistance that demonstrates lowlevel vancomycin resistance, while the second category is the acquired resistance where enterococci can become resistant to vancomycin by acquisition of genetic information from another organism (3) . Enterococcal infections can be lethal, particularly those caused by VRE. VRE primarily resides in the human digestive system and the female genital tract. According to the CDC, the number of nosocomial VRE isolates increased in the United States 20-fold between 1989 and 1993. VRE is now the second to third most common cause of nosocomial infections in the USA (4) .
Phloroglucinols are a class of natural product distributed in plants, marine sponges, and microorganisms. They exhibit various types of structural features, and various biological activities including antibacterial, antifungal, antitumor, antioxidant, antiviral, and antimalarial (5) (6) (7) (8) . Isnansetyo et al. reported the vancomycinresistant S. aureus (VRSA) and VRE activities of 2,4diacetylphloroglucinol (DAPG) with MICs of 4 and 8 g/mL, respectively (9) . Acylphloroglucinols, chemically referred to as 1,3,5-trihydroxybenzenes substituted with at least one acyl substituent are distributed mainly in plants and they are characterized by the presence of one, two, or more acyl phloroglucinol moieties (7) .
Many research efforts have been conducted to find potential anti-MRSA and VRE drug leads from natural sources. In our current study, we have screened a number of plant extracts for antibacterial activity. Amongst the screened plants, Ivesia gordonii showed promising activities towards both MRSA and VRE. Ivesia is a genus of flowering plants in the family Rosaceae, generally known as mousetails. They are perennial herbs native to the USA, but are distributed to western regions of North America (10). The plants grow in rocky mountainous regions under extremely dry conditions, and have developed ways and means to avoid drought or minimize water loss. Ivesia gordonii (Hook.) Torr. & A. Gray, commonly known as Gordon's ivesia, has not been subjected previously to any chemical or biological investigations.
Bioassay-guided fractionation of the EtOH crude extract of I. gordonii concluded that the antimicrobial and antifungal activities are located in the CHCl 3 soluble fraction. Separation and purification of this via centrifugal preparative chromatography (using a Chromatotron  ) led to the isolation of a new dimeric acylphloroglucinol (1), together with the corresponding known monomeric compound 2 (Figure 1 ). The structures of the two compounds were characterized using 1D-and 2D-NMR spectroscopy, including COSY, HMQC, HMBC, ROESY experiments, and HRESIMS. The 1 H and 13 C NMR spectroscopic data of 2 were in agreement with those reported previously for 1,5-dihydroxy-2-(2′-methylpropionyl)-3-methoxy-6-methylbenzene, an acyl phloroglucinol isolated from Hypericum beanii (11) . Compound 1 was isolated as yellow oil with a molecular formula of C 25 H 32 O 8 determined by positive ion HRESIMS (m/z 461.2056 [M+H] + ). The UV spectrum showed two maxima at  max 285 and 330 nm, suggesting the presence of an aromatic chromophore, and the IR spectra showed absorption at 1617 cm -1 , for the presence of a carbonyl group(s). The molecular formula of 1 was calculated for ten degrees of unsaturation, thereby suggesting the presence of two aromatic rings. Comprehensive 1 H and 13 C NMR data are shown in Table 1 . The 1 H NMR spectrum displayed four 3H singlets at δ H 3.97 and 4.02, attributed to C-2-OMe and C-6′-OMe groups, respectively, and two deshielded methyl groups at δ H 2.09 and 2.16 substituted at C-5 and C-5′ positions of the two benzene rings. It also showed a diphenylmethylene group (δ H 3.73 ppm, 2H), four overlapping methyl doublets (δ H 1.19 ppm, d, 12H, J= 7.0 Hz), two multiplets (δ H 3.99 and 3.74 ppm, each 1H, C-2′′ and C-2′′′), as well as four OH protons at δ H 8.8, 8.9, 12.7, and 13.6, of which the two deshielded phenolic protons were chelated with carbonyl groups peri to each other. The 1 H NMR spectrum did not show any proton in the aromatic region, thereby suggesting both the aromatic rings are fully substituted. The 13 C NMR spectrum, together with the DEPT experiment for multiplicity determination, showed the presence of one diphenylmethylene (δ c 17.8, t), two methoxy groups (δ c 62.0 and 65.2, 2 x q), two shielded methyl groups (δ c 8.0 and 8.9, 2 x q), and two carbonyl carbons in the low-field region (δ c 209.9 and 212.2, 2 x s). In addition, it also revealed signals for twelve quaternary carbons indicating the presence of two fully substituted benzene rings, of which the six deshielded carbons resonated at δ c 154.8, 156.2, 159.3, 159.6, 162.1, and 163.1, indicating that they are attached to electron withdrawing groups. The HMBC spectrum showed that the OMe protons at δ H 3.97 and 4.02 correlated with the carbons C-2 (δ c 154.8) and C-6′ (δ c 159.3), respectively, to which they were directly attached. In addition, the signal at δ H 3.73 (Ar-CH 2 -Ar) showed cross-peaks with four aromatic carbons, of which two of them were assigned for ring A (δ c 110.1, C-1; δ c 154.8, C-2), and the other two for ring B (δ c 107.8, C-1′; δ c 159.3, C-6′). This confirmed that the two aromatic rings are connected via a CH 2 -bridge. In addition, HMBC also showed 2 J and 3 J-correlations between signals at δ H 2.09 (H-5-Me) and δ c 110.9 (C-5), δ c 162.1 (C-4) and 159.6 (C-6), and between 2.16 (H-5′-Me) and δ c 110.4 (C-5′), δ c 163.1 (C-4′), and δ c 159.3 (C-6′). A complete assignment of the protons and carbons was accomplished by means of the HMQC, HMBC, COSY, and ROESY experiments ( Figure 2 ). Finally, the ROESY spectrum revealed correlation between C-6-OH (δ H 8.95) and Ar-CH 2 -Ar (δ H 3.73) protons, as well as between C-2′-OH (δ H 8.82) and Ar-CH 2 -Ar protons, suggesting they are in close spatial proximity. Based on the foregoing data, the structure of the compound was assigned as 1. In vitro antimicrobial and antifungal activities were evaluated for compounds 1 and 2, in addition to the CHCl 3 soluble fraction. Antimicrobial activity was evaluated against the bacteria S. aureus, MRSA, Escherichia coli, Pseudomonas aeruginosa, Mycobacterium intracellulare, the yeasts Candida albicans, C. glabrata, and C. krusei, and the fungi Cryptococcus neoformans, and Aspergillus fumigatus (Tables 2 and 3 ). All compounds were inactive against E. coli, P. aeruginosa, C. glabrata, and A. fumigatus at 20 µg/mL. Activities against S. aureus and MRSA were observed for the isolated compounds where compound 1 was more potent than compound 2 with IC 50 /MIC of 0.10/1.25 µg/mL and 0.05/0.31 µg/mL (vs. IC 50 /MIC of 7.2/20 µg/mL and 6.2/20 µg/mL for 2). So, it could be concluded that the dimerization of acylphloroglucinol moieties could enhance anti-staphylococcal activity. Antifungal activity was observed for compound 2, and was stronger against C. neoformans with an IC 50 of 4.11 µg/mL compared with other species (Table 2 ). However, it was reported that 2 had moderate anti-staphylococcal activity, but it was evaluated as a mixture with its 2-methylbutanoyl analog (11) . The VRE activities were evaluated against three strains, including two resistant (Enterococcus faecium ATCC 700221 and E. faecalis
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In an attempt to better understand the influence of acyl or acetyl moieties on the activity against MRSA and VRE, the mono-and diacetylphloroglucinols (4 and 5) were prepared from the commercially available phloroglucinol (3), according to the previously reported procedure [12] (Scheme 1), and evaluated for their in vitro activities against SA, MRSA, and VRE ( Table 3) . Structures of 4 and 5 were confirmed by comparing the NMR spectral data with those reported in the literature [12] as acetylphloroglucinol and 2,4-diacetylphloroglucinol (DAPG), respectively. Furthermore, the identity of 5 was substantiated by direct comparison with an authentic sample of DAPG, procured from a commercial source. Compound 5 showed potent activity against S. aureus, MRSA, and VRE (ATCC 700221), comparable with the commercially available DAPG, which showed IC 50 /MIC values in the range of 0.05-0.27/ 2.50-6.25, 0.04-0.23/1.25-2.50, and 0.28-0.86/1.25-2.50 µg/mL, respectively, while compounds 3 and 4 were inactive. The above data suggested that the presence of two acyl or acetyl groups is very crucial for the antimicrobial activity of either compound 1 or 5, especially against S. aureus, MRSA, and VRE, compared with compounds 2 and 4, respectively. By comparing the activity between dimer 1 and monomer 5, (i.e., both containing two acyl units) it was deduced that dimerization improves the selectivity and increases the potency against S. aureus, MRSA, and VRE. This is the first report of ivesinol (1) from a natural source. However, the structure of 1 was suggested earlier for β-kosin in 1952 (13) . The structure was then rejected in 1963 by Orth and Riedl (14) , and finally in 1974, β-kosin was proved to consist of a mixture of three alkylated methylene-bis-pseudo-aspidinols (15) .
The MRSA activity of monomeric acylphoroglucinol has been reported previously (16) (17) (18) , while the activity of dimeric acylphloroglucinols (1) derived from monomers, such as 2, had not been reported. Finally, the potent and selective activity of the dimeric acylphoroglucinol ivesinol (1) Fr. 31-46 (35.9 mg) was purified by CPTLC, using a 1 mm silica gel disc, and eluted with CH 2 Cl 2 : n-hexane (8:2), which afforded compound 2 (22.3 mg) and β-sitosterol (3.2 mg). 12.8/NT/NT 3.9/NT/NT >20/NT/NT >20/NT/NT >20/NT/NT 1 0.10/1.25/>20 0.05/0.31/>20 0.22/1.25/>20 0.48/>20/>20 0.28/>20/>20 2 7.2/20/>20 6.2/20/>20 13.9/>20/>20 >20/>20/>20 >20/>20/>20 5 0.3/2.5/20 0.23/2.5/20 0.86/2.50/>20 1.10/10.0/>20 1.1/10/>20 DAPG 0.05/6.25/1.25 0.04/1.25/5.0 0.28/1.25/>20 >20/>20/>20 0.33/10/>20 Ciprofloxacin 0.13/0.5/1.0 0.13/0.5/1.0 >20/>20/>20 0.25/0.78/6.25 0.22/0.39/6.25 Vancomycin 0.37/0.62/>20 0.47/1.25/5.0 >20/>20/>20 0.73/1.25/>20 3.8/10/>20 Methicillin 0.42/3.13/12.5 >20/>20/>20 >20/>20/>20 15.3/25/50 14.2/50.0/50.0
